Elekta signs agreement to acquire assets of Mexican distributor, AEESA
MEXICO CITY, April 1, 2015 – Elekta (EKTA-B.ST) announced today that it has signed an agreement to acquire the service business as well as personnel of Mexican distributor, Asesores Electrónicos Especializados S.A. de C.V. (AEESA). The acquisition will bring Elekta closer to its customers, facilitating growth in a market with strong potential.
Jay Hoey, Elekta’s Executive Vice President of Region North America, says: “We have been working with AEESA in Mexico since 2001 to grow our installed base in the country and expand the reach of radiation therapy to underserved populations. With a direct presence in Mexico, we can increase our focus on customers and plan for continued growth in the region.”
Peter Gaccione, Senior Vice President, and Head of Mexico for Elekta says: “The Mexican government has made radiation therapy a top priority. Consequently, we are excited to establish a direct presence in the country to help more cancer patients benefit from this life-saving treatment.
“Elekta will now take responsibility for marketing, sales, service, software support and after-sales revenue as it manages and fulfills existing and new service support contracts directly with its customers,” adds Gaccione.
Elekta will assume all service contract revenue from AEESA starting on April 1, 2015.
This asset acquisition is expected to add approximately 0.4 percent to Elekta’s revenues on an annual basis. The transaction is expected to be accretive to Elekta earnings per share (EPS) during Elekta’s fiscal year 2015/16.
# # #
For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time
Tobias Bülow, Director Financial Communication, Elekta AB
Tel: +46 722 215 017, e-mail: tobias.bulow@elekta.com
Time zone: CET: Central European Time
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on April 1, 2015.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.